Clinical Trials Logo

Clinical Trial Summary

Rationale: Although most patients experience significant pain relief after total shoulder arthroplasty (TSA), pain persists for some patients even after surgery. The endogenous pain system may be involved in persisting postoperative pain in total knee arthroplasty (TKA) and total hip arthroplasty (THA) patients, but this has never been studies for TSA patients. Furthermore, psychological factors and coping strategies may also be of interest but have not yet been extensively studied in TSA patients. Objective: The primary objective is to explore whether central sensitization and/or abnormal CPM responses are present in (a subgroup of) patients who will receive shoulder arthroplasty for osteoarthritis, and whether shoulder arthroplasty produces change in these measures of the endogenous pain modulatory system. The secondary objective, in case patients with altered endogenous pain modulation are found, is to explore if change in pain over time, psychological factors and coping strategies differ between patients with and without altered pain modulation. Study design: An exploratory prospective observational cohort study. Study population: Patients (age 18 years or older) who are scheduled to undergo shoulder arthroplasty for osteoarthritis, at the Reinier Haga Orthopaedic Centre. Intervention (if applicable): Not applicable. Main study parameters/endpoints: The main study parameters are CPM and TS values at baseline and at 3 and 6 months after surgery, as well as the absence/presence of allodynia at baseline and at 3 and 6 months after surgery. Nature and extent of the burden and risks associated with participation, benefit and group relatedness: The burden of participation will consist of completing questionnaires at baseline and at three and six months after surgery. In addition, subjects will undergo psychophysical testing at 3 moments, which can lead to redness or a burning sensation of the skin during the first 24 hours after testing. The investigators do not expect any additional risks associated with participation. There is no direct benefit for the subjects.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05861960
Study type Observational
Source Reinier Haga Orthopedisch Centrum
Contact Brechtje Hesseling, MSc
Phone +31792065595
Email onderzoek@rhoc.nl
Status Recruiting
Phase
Start date March 4, 2024
Completion date August 2025

See also
  Status Clinical Trial Phase
Recruiting NCT05615246 - Exactech Humeral Reconstruction Prosthesis of Shoulder Arthroplasty PMCF (HRP)
Not yet recruiting NCT04448106 - Autologous Adipose Tissue-Derived Mesenchymal Stem Cells (AdMSCs) for Osteoarthritis Phase 2
Not yet recruiting NCT06032416 - DenCT Shoulder Bone Quality Evaluation N/A
Enrolling by invitation NCT05067543 - Perform Humeral System Study
Completed NCT04641546 - Effectiveness of Occupation-Based Intervention Compared With Therapeutic Exercise for Older Adults With Shoulder OA. N/A
Recruiting NCT05868148 - Shoulder iD™ Primary Reversed Glenoid Outcomes Clinical Study
Completed NCT03431857 - Multi Centre Study on TESS V2 Shoulder System
Recruiting NCT06078865 - FX Shoulder Prospective Clinical Study
Recruiting NCT04929951 - The Effect of Micro Fragmented Adipose Tissue (MFAT) on Shoulder Osteoarthritis Phase 1
Recruiting NCT04968405 - Catalyst CSR Shoulder System for Semi or Total Shoulder Arthroplasty N/A
Enrolling by invitation NCT05500066 - AEQUALIS™ FLEX REVIVE™ Study (REVIVE)
Active, not recruiting NCT05002959 - TESS V3 Modular Total Shoulder System PMCF
Recruiting NCT06077942 - FX Shoulder Solutions Retrospective / Prospective Clinical Study
Active, not recruiting NCT06171542 - Efficacy of a Single Image Guided Injection of CTM for Glenohumeral Arthritis Phase 1
Recruiting NCT05487274 - TSA v RSA in Osteoarthritic Shoulders With Greater Than 15 Degrees of Retroversion N/A